Valentina Di Iorio

Peptide receptor radionuclide therapy with 177Lu-DOTATATE in advanced bronchial carcinoids: prognostic role of thyroid transcription factor 1 and 18F-FDG PET

Annarita Ianniello, Maddalena Sansovini, Stefano Severi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 100 citations · Full text

Prognostic Role, Medicine, Radionuclide Therapy +13

Feasibility and utility of re-treatment with 177Lu-DOTATATE in GEP-NENs relapsed after treatment with 90Y-DOTATOC

Stefano Severi, Maddalena Sansovini, Annarita Ianniello et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2015 · 68 citations

Immunology, Treatment Option, Pharmacotherapy +2

Combined use of 177Lu-DOTATATE and metronomic capecitabine (Lu-X) in FDG-positive gastro-entero-pancreatic neuroendocrine tumors

Silvia Nicolini, Lisa Bodei, Alberto Bongiovanni et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2021 · 57 citations · Full text

Pancreatic Cancer, Medicine, Neuroendocrine Disorder +5

Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients

Giovanni Paganelli, Anna Sarnelli, Stefano Severi et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 56 citations

Urology, Medicine, Polyglutamate Parotid +6

Peptide receptor radionuclide therapy in patients with metastatic progressive pheochromocytoma and paraganglioma: long-term toxicity, efficacy and prognostic biomarker data of phase II clinical trials

Stefano Severi, Alberto Bongiovanni, M Ferrara et al. · ESMO Open · 2021 · 56 citations · Full text